These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 17250855

  • 1. Spironolactone improves structure and increases tone in the cerebral vasculature of male spontaneously hypertensive stroke-prone rats.
    Rigsby CS, Pollock DM, Dorrance AM.
    Microvasc Res; 2007 May; 73(3):198-205. PubMed ID: 17250855
    [Abstract] [Full Text] [Related]

  • 2. Regulation of myogenic tone and structure of parenchymal arterioles by hypertension and the mineralocorticoid receptor.
    Pires PW, Jackson WF, Dorrance AM.
    Am J Physiol Heart Circ Physiol; 2015 Jul 01; 309(1):H127-36. PubMed ID: 25910805
    [Abstract] [Full Text] [Related]

  • 3. Effects of spironolactone on cerebral vessel structure in rats with sustained hypertension.
    Rigsby CS, Ergul A, Portik Dobos V, Pollock DM, Dorrance AM.
    Am J Hypertens; 2011 Jun 01; 24(6):708-15. PubMed ID: 21350432
    [Abstract] [Full Text] [Related]

  • 4. Intact female stroke-prone hypertensive rats lack responsiveness to mineralocorticoid receptor antagonists.
    Rigsby CS, Burch AE, Ogbi S, Pollock DM, Dorrance AM.
    Am J Physiol Regul Integr Comp Physiol; 2007 Oct 01; 293(4):R1754-63. PubMed ID: 17670862
    [Abstract] [Full Text] [Related]

  • 5. Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats.
    Dorrance AM, Osborn HL, Grekin R, Webb RC.
    Am J Physiol Regul Integr Comp Physiol; 2001 Sep 01; 281(3):R944-50. PubMed ID: 11507012
    [Abstract] [Full Text] [Related]

  • 6. Elevated production of 20-HETE in the cerebral vasculature contributes to severity of ischemic stroke and oxidative stress in spontaneously hypertensive rats.
    Dunn KM, Renic M, Flasch AK, Harder DR, Falck J, Roman RJ.
    Am J Physiol Heart Circ Physiol; 2008 Dec 01; 295(6):H2455-65. PubMed ID: 18952718
    [Abstract] [Full Text] [Related]

  • 7. Dorsal cerebral collaterals of stroke-prone spontaneously hypertensive rats (SHRSP) and Wistar Kyoto rats (WKY).
    Coyle P.
    Anat Rec; 1987 May 01; 218(1):40-4. PubMed ID: 3605659
    [Abstract] [Full Text] [Related]

  • 8. Mineralocorticoid receptors/epithelial Na(+) channels in the choroid plexus are involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats.
    Nakano M, Hirooka Y, Matsukawa R, Ito K, Sunagawa K.
    Hypertens Res; 2013 Mar 01; 36(3):277-84. PubMed ID: 23096235
    [Abstract] [Full Text] [Related]

  • 9. Doxycycline, a matrix metalloprotease inhibitor, reduces vascular remodeling and damage after cerebral ischemia in stroke-prone spontaneously hypertensive rats.
    Pires PW, Rogers CT, McClain JL, Garver HS, Fink GD, Dorrance AM.
    Am J Physiol Heart Circ Physiol; 2011 Jul 01; 301(1):H87-97. PubMed ID: 21551278
    [Abstract] [Full Text] [Related]

  • 10. Temporary mineralocorticoid receptor antagonism during the development of hypertension improves cerebral artery dilation.
    McClain JL, Dorrance AM.
    Exp Biol Med (Maywood); 2014 May 01; 239(5):619-27. PubMed ID: 24625441
    [Abstract] [Full Text] [Related]

  • 11. Tempol, a superoxide dismutase mimetic, prevents cerebral vessel remodeling in hypertensive rats.
    Pires PW, Deutsch C, McClain JL, Rogers CT, Dorrance AM.
    Microvasc Res; 2010 Dec 01; 80(3):445-52. PubMed ID: 20600163
    [Abstract] [Full Text] [Related]

  • 12. Stroke-prone spontaneously hypertensive rats lose their ability to auto-regulate cerebral blood flow prior to stroke.
    Smeda JS, VanVliet BN, King SR.
    J Hypertens; 1999 Dec 01; 17(12 Pt 1):1697-705. PubMed ID: 10658935
    [Abstract] [Full Text] [Related]

  • 13. A high-potassium diet reduces infarct size and improves vascular structure in hypertensive rats.
    Dorrance AM, Pollock DM, Romanko OP, Stepp DW.
    Am J Physiol Regul Integr Comp Physiol; 2007 Jan 01; 292(1):R415-22. PubMed ID: 16917016
    [Abstract] [Full Text] [Related]

  • 14. Tumor necrosis factor-α inhibition attenuates middle cerebral artery remodeling but increases cerebral ischemic damage in hypertensive rats.
    Pires PW, Girgla SS, Moreno G, McClain JL, Dorrance AM.
    Am J Physiol Heart Circ Physiol; 2014 Sep 01; 307(5):H658-69. PubMed ID: 25015967
    [Abstract] [Full Text] [Related]

  • 15. Congenic removal of a QTL for blood pressure attenuates infarct size produced by middle cerebral artery occlusion in hypertensive rats.
    Yao H, Cui ZH, Masuda J, Nabika T.
    Physiol Genomics; 2007 Jun 19; 30(1):69-73. PubMed ID: 17327494
    [Abstract] [Full Text] [Related]

  • 16. Stroke development in stroke-prone spontaneously hypertensive rats alters the ability of cerebrovascular muscle to utilize internal Ca2+ to elicit constriction.
    Smeda JS.
    Stroke; 2003 Jun 19; 34(6):1491-6. PubMed ID: 12750542
    [Abstract] [Full Text] [Related]

  • 17. Impaired functional recovery after stroke in the stroke-prone spontaneously hypertensive rat.
    McGill JK, Gallagher L, Carswell HV, Irving EA, Dominiczak AF, Macrae IM.
    Stroke; 2005 Jan 19; 36(1):135-41. PubMed ID: 15569870
    [Abstract] [Full Text] [Related]

  • 18. Changes in the composition of the thoracic aortic wall in spontaneously hypertensive rats treated with losartan or spironolactone.
    Han WQ, Wu LY, Zhou HY, Zhang J, Che ZQ, Wu YJ, Liu JJ, Zhu DL, Gao PJ.
    Clin Exp Pharmacol Physiol; 2009 May 19; 36(5-6):583-8. PubMed ID: 19673944
    [Abstract] [Full Text] [Related]

  • 19. Focal Ischemic Injury with Complex Middle Cerebral Artery in Stroke-Prone Spontaneously Hypertensive Rats with Loss-Of-Function in NADPH Oxidases.
    Yao H, Ferdaus MZ, Zahid HM, Ohara H, Nakahara T, Nabika T.
    PLoS One; 2015 May 19; 10(9):e0138551. PubMed ID: 26389812
    [Abstract] [Full Text] [Related]

  • 20. Prevention of stroke and preservation of the functions of cerebral arteries by treatment with perindopril in stroke-prone spontaneously hypertensive rats.
    Wang H, Smeda JS, Lee RM.
    Can J Physiol Pharmacol; 1998 Jan 19; 76(1):26-34. PubMed ID: 9564546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.